Eli Lilly and Company (LLY) News Today $779.60 +0.32 (+0.04%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$778.00 -1.60 (-0.20%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Eli Lilly and Company Up Today?Toggle Visibility of Why Is Eli Lilly and Company Up Today?Eli Lilly and Company (LLY) shares have risen amid a series of positive clinical data releases, upbeat analyst commentary, and strong sales forecasts. Positive Sentiment: MarketBeat names LLY one of the top pharmaceutical stocks to research, highlighting its robust pipeline and investor interest. Top Pharmaceutical Stocks To Research - July 4th Positive Sentiment: Lilly reports that its Phase 3 tirzepatide obesity study continues to show game-changing efficacy and safety, bolstering future sales expectations. Eli Lilly’s Tirzepatide Study: A Potential Game-Changer in Obesity Treatment Positive Sentiment: A Phase 3 update on Lilly’s orforglipron diabetes candidate shows promising blood-sugar reductions, reinforcing its late-stage pipeline strength. Eli Lilly’s Orforglipron Study: A Potential Game-Changer in Diabetes Treatment Positive Sentiment: Lilly and Regeneron’s collaboration on a novel obesity treatment advances, signaling broadened R&D partnerships. Eli Lilly and Regeneron: Exploring New Frontiers in Obesity Treatment Positive Sentiment: Update on Lilly and Loxo Oncology’s pirtobrutinib trial highlights potential breakthroughs in CLL/SLL therapy. Eli Lilly and Loxo Oncology’s Pirtobrutinib Trial: A Potential Game-Changer for CLL/SLL Treatment Positive Sentiment: A novel trial combining ixekizumab and tirzepatide for psoriatic arthritis shows encouraging efficacy data. Eli Lilly’s Innovative Approach: Combining Ixekizumab and Tirzepatide for Psoriatic Arthritis Positive Sentiment: Lilly’s new Phase 2 diabetes study is on track to deliver pivotal data, underscoring its broad metabolic franchise. Eli Lilly’s New Diabetes Study: A Potential Game-Changer? Positive Sentiment: UBS projects strong sales growth for Lilly’s Zepbound and Mounjaro weight-loss drugs, fueling revenue upside. UBS Sees Strong Sales Outlook for Eli Lilly’s Zepbound and Mounjaro Positive Sentiment: RBC Capital Markets highlights a “tremendous opportunity” for Lilly in the Alzheimer’s disease market. Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets Positive Sentiment: MarketBeat also lists LLY among the best pharmaceutical stocks worth watching, reflecting sustained investor interest. Best Pharmaceutical Stocks Worth Watching - July 3rd Positive Sentiment: Zacks notes that non-obesity products like Verzenio and Taltz are driving sales growth alongside its GLP-1 blockbusters. Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth Neutral Sentiment: Barron’s discusses growing competition in the weight-loss market, noting several companies targeting Lilly’s GLP-1 leadership. Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns. Posted 11h agoAI Generated. May Contain Errors. LLY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Top Pharmaceutical Stocks To Research - July 4thJuly 4 at 4:31 PM | marketbeat.comEli Lilly’s Tirzepatide Study: A Potential Game-Changer in Obesity TreatmentJuly 4 at 12:13 PM | tipranks.comEli Lilly’s Orforglipron Study: A Potential Game-Changer in Diabetes TreatmentJuly 4 at 12:13 PM | tipranks.comEli Lilly’s Orforglipron Study: A Potential Game-Changer in Diabetes Treatment?July 4 at 12:13 PM | tipranks.comEli Lilly and Regeneron: Exploring New Frontiers in Obesity TreatmentJuly 4 at 12:13 PM | tipranks.comEli Lilly and Loxo Oncology’s Pirtobrutinib Trial: A Potential Game-Changer for CLL/SLL TreatmentJuly 4 at 12:13 PM | tipranks.comEli Lilly’s Innovative Approach: Combining Ixekizumab and Tirzepatide for Psoriatic ArthritisJuly 4 at 12:13 PM | tipranks.comEli Lilly’s New Diabetes Study: A Potential Game-Changer?July 4 at 12:13 PM | tipranks.comUBS Sees Strong Sales Outlook for Eli Lilly’s Zepbound and MounjaroJuly 4 at 7:44 AM | msn.comMeritage Portfolio Management Lowers Stock Position in Eli Lilly and Company (NYSE:LLY)July 4 at 5:47 AM | marketbeat.comClarity Capital Partners LLC Sells 1,987 Shares of Eli Lilly and Company (NYSE:LLY)July 4 at 5:47 AM | marketbeat.comBuffington Mohr McNeal Sells 2,087 Shares of Eli Lilly and Company (NYSE:LLY)July 4 at 5:47 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Holdings Raised by Teacher Retirement System of TexasJuly 4 at 5:34 AM | marketbeat.comLatitude Advisors LLC Has $1.86 Million Position in Eli Lilly and Company (NYSE:LLY)July 4 at 5:26 AM | marketbeat.comMainstream Capital Management LLC Grows Holdings in Eli Lilly and Company (NYSE:LLY)July 4 at 5:17 AM | marketbeat.comPinnacle Financial Partners Inc Raises Holdings in Eli Lilly and Company (NYSE:LLY)July 4 at 5:05 AM | marketbeat.comKanawha Capital Management LLC Increases Stock Position in Eli Lilly and Company (NYSE:LLY)July 4 at 5:05 AM | marketbeat.comMoody Lynn & Lieberson LLC Has $69.41 Million Stock Holdings in Eli Lilly and Company (NYSE:LLY)July 4 at 5:05 AM | marketbeat.comAaron Wealth Advisors LLC Has $4.67 Million Position in Eli Lilly and Company (NYSE:LLY)July 4 at 5:04 AM | marketbeat.comLilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.July 4 at 2:01 AM | barrons.comEli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital MarketsJuly 3 at 5:55 PM | msn.comBest Pharmaceutical Stocks Worth Watching - July 3rdJuly 3 at 3:42 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) is Klingenstein Fields & Co. LP's 5th Largest PositionJuly 3 at 5:38 AM | marketbeat.comKeybank National Association OH Has $111.37 Million Stock Holdings in Eli Lilly and Company (NYSE:LLY)July 3 at 5:37 AM | marketbeat.comYukon Wealth Management Inc. Takes $1.40 Million Position in Eli Lilly and Company (NYSE:LLY)July 3 at 5:18 AM | marketbeat.comRossby Financial LCC Has $808,000 Position in Eli Lilly and Company (NYSE:LLY)July 3 at 5:18 AM | marketbeat.comSvenska Handelsbanken AB publ Takes $28.90 Million Position in Eli Lilly and Company (NYSE:LLY)July 3 at 5:18 AM | marketbeat.comSumitomo Mitsui DS Asset Management Company Ltd Acquires 3,377 Shares of Eli Lilly and Company (NYSE:LLY)July 3 at 5:09 AM | marketbeat.comSmith Group Asset Management LLC Sells 535 Shares of Eli Lilly and Company (NYSE:LLY)July 3 at 5:00 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Vontobel Holding Ltd.July 3 at 4:59 AM | marketbeat.comAstoria Portfolio Advisors LLC. Acquires 1,092 Shares of Eli Lilly and Company (NYSE:LLY)July 3 at 4:59 AM | marketbeat.comSalomon & Ludwin LLC Purchases 396 Shares of Eli Lilly and Company (NYSE:LLY)July 3 at 4:59 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Bought by Mather Group LLC.July 3 at 4:59 AM | marketbeat.comPharmaceutical Stocks Worth Watching - July 2ndJuly 2 at 4:49 PM | marketbeat.comWeight Loss Pill a Potential Game-Changer for Eli Lilly Stock (LLY)July 2 at 4:15 PM | tipranks.comEli Lilly and Loxo Oncology’s Promising CLL/SLL Study UpdateJuly 2 at 12:41 PM | tipranks.comSage Advisors LLC Grows Holdings in Eli Lilly and Company (NYSE:LLY)July 2 at 5:49 AM | marketbeat.comAlta Advisers Ltd Grows Stake in Eli Lilly and Company (NYSE:LLY)July 2 at 5:49 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Bought by New Millennium Group LLCJuly 2 at 5:39 AM | marketbeat.com419 Shares in Eli Lilly and Company (NYSE:LLY) Acquired by Barnes Dennig Private Wealth Management LLCJuly 2 at 5:39 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Riverstone Advisors LLCJuly 2 at 5:39 AM | marketbeat.comG&S Capital LLC Invests $381,000 in Eli Lilly and Company (NYSE:LLY)July 2 at 5:39 AM | marketbeat.comRedJay Asset Management Inc. Purchases New Stake in Eli Lilly and Company (NYSE:LLY)July 2 at 5:39 AM | marketbeat.comSpinnaker Trust Cuts Stock Holdings in Eli Lilly and Company (NYSE:LLY)July 2 at 5:39 AM | marketbeat.comIntelligence Driven Advisers LLC Reduces Position in Eli Lilly and Company (NYSE:LLY)July 2 at 5:39 AM | marketbeat.comWASHINGTON TRUST Co Has $15.30 Million Position in Eli Lilly and Company (NYSE:LLY)July 2 at 5:25 AM | marketbeat.comNicholson Meyer Capital Management Inc. Makes New $2.05 Million Investment in Eli Lilly and Company (NYSE:LLY)July 2 at 5:25 AM | marketbeat.com2 Growth Stocks to Buy Hand Over Fist in JulyJuly 2 at 4:01 AM | fool.comBest Pharmaceutical Stocks Worth Watching - July 1stJuly 1, 2025 | marketbeat.comAmeritas Advisory Services LLC Sells 4,282 Shares of Eli Lilly and Company (NYSE:LLY)July 1, 2025 | marketbeat.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼1.320.54▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼11589▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Today Biogen News Today Incyte News Today Moderna News Today Viking Therapeutics News Today Vertex Pharmaceuticals News Today AbbVie News Today Johnson & Johnson News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
